Robert Wendel Naumann

Robert Wendel Naumann

Atrium Health - / United States
Others
AD Scientific Index ID: 4927253
person_outline Robert Wendel Naumann's MOST POPULAR ARTICLES
1-) Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancerDG Mutch, M Orlando, T Goss, MG Teneriello, AN Gordon, SD McMeekin, ...Journal of Clinical Oncology 25 (19), 2811-2818, 20074492007
2-) Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I/II CheckMate 358 trialRW Naumann, A Hollebecque, T Meyer, MJ Devlin, A Oaknin, J Kerger, ...Journal of Clinical Oncology 37 (31), 2825, 20192202019
3-) PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum …RW Naumann, RL Coleman, RA Burger, EA Sausville, E Kutarska, ...J Clin Oncol 31 (35), 4400-4406, 20131982013
4-) Sexual dysfunction following vulvectomyMS Green, RW Naumann, M Elliot, JB Hall, RV Higgins, JH GrigsbyGynecologic Oncology 77 (1), 73-77, 20002052000
5-) Management strategies for recurrent platinum-resistant ovarian cancerRW Naumann, RL ColemanDrugs 71, 1397-1412, 20111822011